P16083 (NQO2_HUMAN) Homo sapiens (Human)
Ribosyldihydronicotinamide dehydrogenase [quinone] UniProtKBInterProSTRINGInteractive Modelling
231 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
68 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Reduced quinone reductase 2 in complex with chloroquine | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×CLQ; | |||
| Oxidized quinone reductase 2 in complex with primaquine | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×1PQ; 2×GOL; | |||
| Oxidized quinone reductase 2 in complex with chloroquine | homo-2-mer | 99.56 | 2×FAD; 2×0TX; 2×ZN; | |||
| Oxidized quinone reductase 2 in complex with CK2 inhibitor DMAT | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×K25; | |||
| Crystal structure analysis of QR2 in complex with resveratrol | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×STL; | |||
| Crystal Structure of Quinone Reductase II | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×ML1; | |||
| Quinone Reductase 2 in Complex with Cancer Prodrug CB1954 | homo-2-mer | 99.56 | 3×ZN; 2×FAD; 2×CB1; | |||
| Design, Synthesis and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Ana… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×465; 1×GOL; | |||
| Design, Synthesis and Biological Evaluation of Potetent Quinoline and Pyrroloquinoline Ammosamide A… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×UXH; | |||
| Casimiroin analog inhibitor of quinone reductase 2 | homo-2-mer | 99.56 | 2×ZN; 2×EWQ; 2×FAD; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×YTR; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 3×MZX; | |||
| Crystal Structure of Quinone Reductase II | homo-2-mer | 99.56 | 2×FAD; 2×ML2; 2×ZN; 2×CL; 2×GOL; | |||
| Crystal Structure of Quinone Reductase II | homo-2-mer | 99.56 | 2×FAD; 2×ML1; 2×ZN; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×ZXZ; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×HGZ; | |||
| Crystal Structure of Quinone Reductase II | homo-2-mer | 99.56 | 2×FAD; 2×ML1; 2×ZN; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×MZX; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 3×RZW; | |||
| Reduced quinone reductase 2 in complex with CK2 inhibitor DMAT | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×K25; | |||
| Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi… | homo-2-mer | 99.56 | 2×ZN; 4×XM5; 2×FAD; | |||
| Reduced quinone reductase 2 in complex with acridine orange | homo-2-mer | 99.56 | 3×ZN; 2×FAD; 2×AO; | |||
| Oxidized quinone reductase 2 in complex with ethidium | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 3×ET; 1×SO4; | |||
| Reduced quinone reductase 2 in complex with ethidium | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 3×ET; | |||
| Oxidized quinone reductase 2 in complex with acridine orange | homo-2-mer | 99.56 | 3×ZN; 2×FAD; 2×AO; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×M42; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×A7B; | |||
| Crystal Structure of Quinone Reductase II in complex with a 2-(4-methoxy-phenyl)-5-methoxy-indol-3-… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×3ZV; 3×SO4; | |||
| Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation | homo-2-mer | 99.56 | 2×ZN; 1×GOL; 2×FAD; 2×M49; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×VAP; | |||
| Oxidized quinone reductase 2 in complex with CK2 inhibitor TBBz | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×K17; | |||
| Oxidized quinone reductase 2 in complex with doxorubicin | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×DM2; | |||
| Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory activi… | homo-2-mer | 99.56 | 2×MXX; 2×FAD; 2×ZN; | |||
| Binding of anti-cancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structu… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×CB1; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×VVV; 2×FAD; | |||
| Crystal structure of quinone reductase 2 in complex with the indolequinone MAC627 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×O73; | |||
| HUMAN QUINONE REDUCTASE TYPE 2 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; | |||
| Quinone Reductase 2 in Complex with Dopamine | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×LDP; | |||
| Human quinone oxidoreductase 2 (NQO2) in complex with the cytostatic prodrug CB1954 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×CB1; | |||
| Synthesis of novel MT3 receptor ligands via unusual Knoevenagel condensation | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×372; 1×GOL; | |||
| Crystal Structure of Quinone Reductase II | homo-2-mer | 99.56 | 2×FAD; 2×ML2; 2×ZN; | |||
| X-ray Crystallographic Structure Activity Relationship (SAR) of Casimiroin and its Analogs Bound to… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×A2Z; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×79X; | |||
| HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×VK3; | |||
| Quinone Reductase 2 in complex with adrenochrome | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×AD1; | |||
| The value crystal structure of apo quinone reductase 2 at 1.35A | homo-2-mer | 99.56 | 6×GOL; 2×ZN; | |||
| The value 'crystal structure of fad quinone reductase 2 at 1.45A | homo-2-mer | 99.56 | 1×GOL; 2×FAD; 2×ZN; | |||
| Crystal Structure of Quinone Reductase II in complex with 2-(4-aminophenyl)-5-methoxy-1-oxy-indol-3… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×3ZU; 3×SO4; | |||
| Crystal structure of FMN quinone reductase 2 in complex with melatonin at 1.55A | homo-2-mer | 99.56 | 2×FMN; 2×ZN; 2×ML1; | |||
| Crystal structure of fad quinone reductase 2 in complex with resveratrol at 1.6A | homo-2-mer | 99.56 | 2×FAD; 2×STL; 2×ZN; 1×GOL; | |||
| Structure of the human quinone reductase 2 (NQO2) in complex with imiquimod | homo-2-mer | 100 | 2×ZN; 2×FAD; 4×6T0; 3×SO4; | |||
| CRYSTAL STRUCTURE OF FMN QUINONE REDUCTASE 2 IN COMPLEX WITH RESVERATROL AT 1.85A | homo-2-mer | 99.56 | 2×FMN; 2×STL; 2×ZN; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×695; | |||
| QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive … | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 1×SO4; 2×V1Z; | |||
| Crystal structure of fad quinone reductase 2 in complex with melatonin at 1.4A | homo-2-mer | 99.56 | 2×FAD; 2×ML1; 2×ZN; | |||
| Structure of the human quinone reductase 2 (NQO2) in complex with crenolanib | homo-2-mer | 100 | 2×ZN; 2×FAD; 2×6T2; | |||
| Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 6a1 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×6A1; 1×IMD; | |||
| Crystal structure of fmn quinone reductase 2 AT 1.55A | homo-2-mer | 99.56 | 2×FMN; 2×ZN; | |||
| Structure of the human quinone reductase 2 (NQO2) in complex with to CL097 | homo-2-mer | 100 | 2×ZN; 2×FAD; 5×SO4; 4×C09; | |||
| Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 5a1 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×TE7; 1×IMD; | |||
| Quinone Reductase 2 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×STI; 4×MRD; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×4X4; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×XRA; | |||
| Structure of the human quinone reductase 2 (NQO2) in complex with volitinib | homo-2-mer | 100 | 2×ZN; 2×FAD; 2×V0L; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×MZC; 2×FAD; | |||
| Quinone Oxidoreductase (NQ02) bound to NSC13000 | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×AA; | |||
| X-ray Structural study of quinone reductase II inhibition by compounds with micromolar to nanomolar… | homo-2-mer | 99.56 | 2×ZN; 2×FAD; 2×52X; | |||
| Structure of the human quinone reductase 2 (NQO2) in complex with pacritinib | homo-2-mer | 100 | 2×FAD; 2×6T3; 4×SO4; 2×ZN; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4fgl.1.A | homo-2-mer | 0.90 | 2×ZN; 2×FAD; 2×CLQ; | 99.57 | ||